Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adenoma, Liver Cell | 2 | 2020 | 32 | 1.420 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2020 | 29 | 0.710 |
Why?
|
Pneumonectomy | 1 | 2022 | 1111 | 0.510 |
Why?
|
Liver Neoplasms | 2 | 2020 | 4313 | 0.470 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2292 | 0.290 |
Why?
|
Mastectomy, Segmental | 3 | 2022 | 972 | 0.250 |
Why?
|
Radiotherapy, Adjuvant | 4 | 2020 | 1791 | 0.250 |
Why?
|
Neoplasm, Residual | 2 | 2024 | 1007 | 0.250 |
Why?
|
Lung Neoplasms | 2 | 2024 | 13245 | 0.160 |
Why?
|
Lymphatic Irradiation | 1 | 2018 | 115 | 0.150 |
Why?
|
Neoadjuvant Therapy | 3 | 2019 | 2821 | 0.150 |
Why?
|
Tumor Burden | 1 | 2024 | 1893 | 0.150 |
Why?
|
Skin Neoplasms | 3 | 2022 | 5797 | 0.150 |
Why?
|
Radiation Pneumonitis | 1 | 2018 | 102 | 0.150 |
Why?
|
Organs at Risk | 1 | 2018 | 358 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2020 | 9273 | 0.130 |
Why?
|
DNA Copy Number Variations | 1 | 2024 | 2012 | 0.130 |
Why?
|
Carcinoma, Lobular | 2 | 2015 | 489 | 0.120 |
Why?
|
Antigens, Neoplasm | 1 | 2022 | 1997 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 1 | 2022 | 1152 | 0.110 |
Why?
|
Melanoma | 2 | 2022 | 5691 | 0.100 |
Why?
|
Watchful Waiting | 1 | 2017 | 509 | 0.100 |
Why?
|
Breast Neoplasms | 5 | 2019 | 21017 | 0.100 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2018 | 801 | 0.100 |
Why?
|
Sarcoma | 1 | 2022 | 1785 | 0.100 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2015 | 1096 | 0.090 |
Why?
|
Receptor, erbB-2 | 3 | 2015 | 2553 | 0.090 |
Why?
|
Mastectomy | 2 | 2015 | 1832 | 0.090 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2018 | 1659 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2022 | 4353 | 0.080 |
Why?
|
Mammaplasty | 1 | 2019 | 1239 | 0.080 |
Why?
|
Rectal Neoplasms | 1 | 2017 | 1152 | 0.080 |
Why?
|
Sex Factors | 1 | 2020 | 10505 | 0.070 |
Why?
|
Neoplasm Staging | 4 | 2022 | 11152 | 0.060 |
Why?
|
Lymph Node Excision | 2 | 2020 | 1303 | 0.050 |
Why?
|
Receptors, Progesterone | 2 | 2015 | 1130 | 0.040 |
Why?
|
Humans | 13 | 2024 | 758381 | 0.040 |
Why?
|
Lung | 1 | 2018 | 9985 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2017 | 6313 | 0.040 |
Why?
|
Lymph Nodes | 2 | 2022 | 3485 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20500 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2022 | 964 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2022 | 733 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1705 | 0.040 |
Why?
|
Extremities | 1 | 2022 | 865 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2015 | 3617 | 0.040 |
Why?
|
Receptors, Estrogen | 2 | 2015 | 2211 | 0.040 |
Why?
|
Thoracic Wall | 1 | 2018 | 199 | 0.030 |
Why?
|
HLA Antigens | 1 | 2022 | 1368 | 0.030 |
Why?
|
Prognosis | 4 | 2019 | 29558 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2018 | 39060 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2022 | 6127 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11709 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2018 | 1680 | 0.030 |
Why?
|
Probability | 1 | 2018 | 2467 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36285 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1705 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2018 | 2896 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13591 | 0.020 |
Why?
|
Survival Rate | 2 | 2015 | 12721 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2017 | 1268 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3840 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5199 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2015 | 2943 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3446 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2500 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3527 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2015 | 58681 | 0.020 |
Why?
|
Heart | 1 | 2018 | 4382 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8554 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 15773 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6852 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6821 | 0.010 |
Why?
|
Phenotype | 1 | 2022 | 16534 | 0.010 |
Why?
|
Aged | 4 | 2018 | 168217 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7985 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8530 | 0.010 |
Why?
|
Male | 1 | 2020 | 358742 | 0.010 |
Why?
|
Middle Aged | 4 | 2018 | 219560 | 0.010 |
Why?
|
Adult | 4 | 2018 | 219916 | 0.010 |
Why?
|
Female | 5 | 2019 | 390316 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 21273 | 0.010 |
Why?
|
Young Adult | 2 | 2015 | 58808 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 39873 | 0.010 |
Why?
|
Neoplasms | 1 | 2024 | 22030 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 54136 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2015 | 80170 | 0.000 |
Why?
|
Concepts
(87)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_